These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 10049669
1. Vascular endothelial growth factor (VEGF165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma. Mercié P, Devianne I, Viallard JF, Faure I, Pellegrin I, Leng B, Dupon M, Barbeau P, Fleury H, Pellegrin JL. Microvasc Res; 1999 Mar; 57(2):208-10. PubMed ID: 10049669 [No Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor levels in serum do not increase following HIV type 1 and HHV8 seroconversion and lack correlation with AIDS-related Kaposi's sarcoma. Renwick N, Weverling GJ, Brouwer J, Bakker M, Schulz TF, Goudsmit J. AIDS Res Hum Retroviruses; 2002 Jul 01; 18(10):695-8. PubMed ID: 12167275 [Abstract] [Full Text] [Related]
3. Classic Kaposi's sarcoma and vascular endothelial growth factor. Redondo P, Sánchez-Carpintero I, Vázquez-Doval J, Quintanilla E. Acta Derm Venereol; 2000 May 01; 80(3):218-9. PubMed ID: 10954221 [No Abstract] [Full Text] [Related]
4. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion. Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM. J Cell Biochem; 2003 May 01; 89(1):133-43. PubMed ID: 12682914 [Abstract] [Full Text] [Related]
5. Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathy. Ascherl G, Hohenadl C, Schatz O, Shumay E, Bogner J, Eckhart L, Tschachler E, Monini P, Ensoli B, Stürzl M. Blood; 1999 Jun 15; 93(12):4232-41. PubMed ID: 10361120 [Abstract] [Full Text] [Related]
6. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count. de Souza VA, Pierrotti LC, Sumita LM, Freire WS, Segurado AA, Pannuti CS. J Med Virol; 2007 Oct 15; 79(10):1562-8. PubMed ID: 17705173 [Abstract] [Full Text] [Related]
7. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology. Morini M, Benelli R, Giunciuglio D, Carlone S, Arena G, Noonan DM, Albini A. Biochem Biophys Res Commun; 2000 Jun 24; 273(1):267-71. PubMed ID: 10873597 [Abstract] [Full Text] [Related]
8. AIDS-related Kaposi's sarcoma in a patient with a normal CD4 count. Power DG, Mulholland PJ, O'Byrne KJ. Clin Oncol (R Coll Radiol); 2008 Feb 24; 20(1):97. PubMed ID: 17954026 [No Abstract] [Full Text] [Related]
9. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts. Samaniego F, Young D, Grimes C, Prospero V, Christofidou-Solomidou M, DeLisser HM, Prakash O, Sahin AA, Wang S. Cell Growth Differ; 2002 Aug 24; 13(8):387-95. PubMed ID: 12193477 [Abstract] [Full Text] [Related]
10. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis. Polstra AM, Cornelissen M, Goudsmit J, van der Kuyl AC. J Med Virol; 2004 Nov 24; 74(3):390-6. PubMed ID: 15368522 [Abstract] [Full Text] [Related]
11. Kaposi's sarcoma in immunosuppressed patients. Penn I. J Clin Lab Immunol; 1983 Sep 24; 12(1):1-10. PubMed ID: 6355477 [No Abstract] [Full Text] [Related]
12. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R. Haematologica; 2000 Aug 24; 85(8):800-5. PubMed ID: 10942925 [Abstract] [Full Text] [Related]
14. AIDS-Kaposi's sarcoma complex: evolution of a full-blown lymphologic syndrome. Witte MH, Witte CL. Lymphology; 1988 Mar 24; 21(1):4-10. PubMed ID: 2456430 [Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. Jacobsen J, Rasmuson T, Grankvist K, Ljungberg B. J Urol; 2000 Jan 24; 163(1):343-7. PubMed ID: 10604387 [Abstract] [Full Text] [Related]
16. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma. Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS. Ann Hematol; 2003 Jan 24; 82(1):19-23. PubMed ID: 12574959 [Abstract] [Full Text] [Related]
17. Basic fibroblast growth factor as a growth factor for SRV-2-infected simian retroperitoneal fibromatosis cells, an animal model for AIDS related Kaposi's sarcoma. Chung CH, Chiang J, Jiang CM, Chen YY, Huang CY, Chen PG, Chen YJ. Neoplasma; 2001 Jan 24; 48(3):192-9. PubMed ID: 11583288 [Abstract] [Full Text] [Related]
18. Kaposi's sarcoma. Coupling herpesvirus to angiogenesis. Boshoff C. Nature; 1998 Jan 01; 391(6662):24-5. PubMed ID: 9422503 [No Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia. Hefler L, Obermair A, Husslein P, Kainz C, Tempfer C. Acta Obstet Gynecol Scand; 2000 Jan 01; 79(1):77-8. PubMed ID: 10646821 [No Abstract] [Full Text] [Related]